Published in AIDS Weekly, September 2nd, 2002
"The ability of human immunodeficiency virus type 1 (HIV-1) to establish latent infections in cells has received renewed attention owing to the failure of highly active antiretroviral therapy to eradicate HIV-1 in vivo," according to Olaf Kutsch and colleagues at the University of Alabama at Birmingham and the Howard Hughes Medical Institute in Birmingham, Alabama. "Despite much study, the molecular bases of HIV-1 latency and reactivation are incompletely understood."
Kutsch and coauthors constructed a HIV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.